ANO3-AS1

Across TCGA pan-cancer cohorts, ANO3-AS1 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated ANO3-AS1 data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher ANO3-AS1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated ANO3-AS1 expression acts as an unfavorable survival marker, although some lineages such as LIHC show a favorable association.

ACC, COAD, and HNSC are the cancer types where ANO3-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	DFS	Tertile	All	0.010	0.667	<.001	135	view →
COAD	OS	Tertile	All	0.408	0.805	<.001	108	view →
HNSC	DFS	Tertile	All	0.183	0.667	<.001	75	view →
KIRP	OS	Tertile	All	0.803	0.943	<.001	69	view →
SKCM	OS	Tertile	II,III,IV	0.095	0.370	.005	57	view →
LUAD	OS	Tertile	III,IV	0.070	0.693	<.001	45	view →
STAD	DFS	Tertile	All	0.196	0.595	.027	36	view →
ESCA	OS	Tertile	IV	0.095	0.512	.008	36	view →
THCA	DFS	Tertile	III,IV	0.783	0.943	.005	24	view →
SARC	DFS	Tertile	All	0.244	0.603	.008	18	view →
LUSC	OS	Tertile	II,III,IV	0.133	0.732	<.001	18	view →
KIRC	OS	Tertile	All	0.457	0.672	.007	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

ANO3-AS1–ACC (DFS)

Open the ACC breakdown →